Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mastectomy pain study: which drug works best?

NCT ID NCT06974656

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested two drugs, dexmedetomidine and lidocaine, given during surgery to control pain after a mastectomy. 40 women took part. The goal was to see which drug delays the need for extra pain medicine and keeps vital signs stable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dexmedetomidine and lidocaine
What this could lead to
If one drug works better, it could offer a more effective way to control pain right after mastectomy, reducing the need for stronger painkillers.
What could go wrong
This is a small, early-stage trial with only 40 people, so results may not apply to everyone. Both drugs have known side effects like low blood pressure or heart rate changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

May 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age from 18 to 65 years. * American Society of Anesthesiology (ASA) physical status II. * Body mass index (BMI) 18.5-35 kg/m2. * Scheduled for modified radical mastectomy. Exclusion Criteria: * Patient's refusal. * Contraindication to the use of local anesthetics. * Cardiovascular disease. * Significant renal/hepatic impairment * Insulin-dependent diabetes mellitus. * Central nervous system or psychiatric disease. * Use of opioids/steroids/clonidine/other α2 agonist/analgesics or any drugs acting on the central nervous system during the previous 2 weeks. * Drug/alcohol abuse. * Inability to comprehend the pain assessment scale.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute disease breast cancer Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE Dexmedetomidine Infusion Lidocaine Modified radical mastectomy Postoperative pain

Contacts and locations

Locations

  • Cairo University

    Cairo, 12613, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.